Arbutus Biopharma Corp (ABUS)
NASDAQ·Healthcare·Biotechnology
$5.13
+0.10%
Mkt Cap $1.02B
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
Implied Upside
+65.9%
Consensus $8.50 vs current $5.13
NASDAQ·Healthcare·Biotechnology
$5.13
+0.10%
Mkt Cap $1.02B
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
+65.9%
Consensus $8.50 vs current $5.13